Allakos Inc. (ALLK)
Data as of , from SEC Form 4 filings.
See up to 3 months of ALLK. The 7-day demo opens the 1M and 3M ranges and puts ALLK on your watchlist.
Start 7-day demoLatest ALLK insider trades
About Allakos Inc. (ALLK)
Allakos Inc. is an SEC registrant, filing under CIK 0001564824, classified as pharmaceutical preparations. We track it alongside the rest of the Health Care sector.
ALLK Form 4 activity by transaction type, last 90 days
No Form 4 activity for ALLK in the last 90 days.
ALLK insider transactions (Form 4)
156 Form 4 filings on record, the earliest from Dec 6, 2024, newest first.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Steven P. James - Director | Derivative | Stock Option (right to buy) | 55,380 | $0.00 | - | |
| Steven P. James - Director | Derivative | Stock Option (right to buy) | 18,800 | $0.00 | - | |
| Steven P. James - Director | Derivative | Stock Option (right to buy) | 16,000 | $0.00 | - | |
| Steven P. James - Director | Derivative | Stock Option (right to buy) | 7,700 | $0.00 | - | |
| Steven P. James - Director | Derivative | Stock Option (right to buy) | 7,700 | $0.00 | - | |
| Steven P. James - Director | Derivative | Stock Option (right to buy) | 99,590 | $0.00 | - | |
| Steven P. James - Director | Derivative | Stock Option (right to buy) | 86,762 | $0.00 | - | |
| Steven P. James - Director | Derivative | Stock Option (right to buy) | 41,000 | $0.00 | - | |
| BVF PARTNERS L P - 10% Owner | Derivative | Common Stock, $0.001 par value | 8,679,726 | - | - | |
| BVF PARTNERS L P - 10% Owner | Derivative | Common Stock, $0.001 par value | 6,777,935 | - | - | |
| BVF PARTNERS L P - 10% Owner | Derivative | Common Stock, $0.001 par value | 855,211 | - | - | |
| Adam Tomasi - Officer | Tax withholding / forfeiture | Common Stock | 21,116 | $1.10 | $23K | |
| Harlan Baird Radford - Officer | Tax withholding / forfeiture | Common Stock | 13,138 | $1.10 | $14K | |
| Robert Alexander - Officer | Tax withholding / forfeiture | Common Stock | 32,466 | $1.10 | $36K | |
| Chin Hyok Lee - Officer | Tax withholding / forfeiture | Common Stock | 10,634 | $1.13 | $12K |
ALLK insider trading FAQ
What is the latest insider trade for ALLK?
Allakos Inc. (ALLK) has filed no insider reports in the last 90 days. The most recent on record is dated 2025-05-15. The full record for ALLK runs to 6 Form 4 filings, the earliest from 2024-12-06. InsiderAlpha adds new Form 4, Form 144 and 8-K filings as they arrive from SEC EDGAR.
How many insiders are buying ALLK stock?
No insider purchases of ALLK were filed in the last 90 days.
How many insiders are selling ALLK stock?
No insider sales of ALLK were filed in the last 90 days.
Where can I see ALLK SEC filings (Form 4, 10-K, 10-Q, 8-K)?
This page collects ALLK Form 4 insider transactions, Form 144 sale notices and 8-K filings in one place. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
More Health Care companies with insider activity
Recent insider filings
6The EDGAR links open each original Form 4, so you can check any number on this page against the filing it came from.
- - Steven P. James view on EDGAR
- - BVF PARTNERS L P view on EDGAR
- - Adam Tomasi view on EDGAR
- - Harlan Baird Radford view on EDGAR
- - Robert Alexander view on EDGAR
- - Chin Hyok Lee view on EDGAR
Related companies with recent insider activity
Learn more
- What the Form 4 transaction codes mean
- Grants, option exercises, gifts and tax withholding are not trades on the market. The codes say which is which.
- Insider activity in Health Care
- Where ALLK's peers are being bought and sold.
- Every recent Form 4
- The market-wide feed, updated as filings arrive from SEC EDGAR.
Follow ALLK with a 7-day demo
- ALLK on your watchlist
- Every ALLK Form 4 filing on record
- Up to 3 months of ALLK price history
- The daily trading plan of ranked insider buys, on a delay, with the plan archive
